Trilobio
About:
Robotics & Synthetic Biology
Website: https://trilo.bio/
Twitter/X: trilobio
Top Investors: Lowercarbon Capital, 1517 Fund, Argon Ventures, Nucleus Capital, Climate Capital Bio
Description:
Trilobio was created to improve synthetic biology and life science research processes by building robotic lab automation modules coupled with an "app store" to package and distribute lab protocols as code. The goal is to deploy fully automated labs that dramatically improve data quality and reproducibility.
Total Funding Amount:
$3M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2021-09-21
Contact Email:
hello(AT)trilo.bio
Founders:
Maximilian Schommer, Roya Amini-Naieni
Number of Employees:
1-10
Last Funding Date:
2023-11-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai